Table 4. Target doses achieved of ACE inhibitors/ARBs and β-blockers.
Agents | Target doses achieved n (%) |
ACE inhibitors / ARBs | 159 (40.3) |
β-blockers | 68 (28.9) |
Agents | Target doses achieved n (%) |
ACE inhibitors / ARBs | 159 (40.3) |
β-blockers | 68 (28.9) |